Decatur Capital Management, Inc. United Therapeutics Corp Transaction History
Decatur Capital Management, Inc.
- $191 Million
- Q1 2025
A detailed history of Decatur Capital Management, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Decatur Capital Management, Inc. holds 9,229 shares of UTHR stock, worth $2.68 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
9,229
Previous 9,208
0.23%
Holding current value
$2.68 Million
Previous $3.25 Million
12.41%
% of portfolio
1.49%
Previous 1.49%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
733Shares Held
43.6MCall Options Held
124KPut Options Held
122K-
Black Rock Inc. New York, NY5.47MShares$1.59 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.29 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$776 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$647 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$611 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...